FMP
SOPHiA GENETICS SA
SOPH
NASDAQ
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
3.02 USD
0.02 (0.662%)
Valuation Date:
Mar 21, 2025 4:00 PM
Share Price on Valuation Date
$3.02
Stock Beta
1.013
Shares Outstanding
66831100